E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/9/2006 in the Prospect News Biotech Daily.

OraSure at sector perform by RBC

RBC Capital Markets rated OraSure Technologies, Inc. at sector perform, speculative risk, following the company's quarterly results. OraSure's revenue increased 0.8% to $17.6 million, above RBC's estimate of $16.4 million and Street consensus of $16.2 million. The launch of Freeze Off (Freeze Spray) is not progressing as planned, leading management to lower its second-half 2006 expectations for the product. Shares of the Bethlehem, Pa.-based medical device company were down $2.12, or 23.56%, at $6.88, on volume of 5,446,321 shares versus the three-month running average of 403,706 shares. (Nasdaq: OSUR)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.